← Open Payments lookup

REBECCA GLEASON: Open Payments

NPI 1972936938 · FLINT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,353 in 67 payments from 11 companies in 2025. Trend: 2023 $594 · 2024 $621 · 2025 $1,353

Food & beverage: $1,353
CompanyPaymentsAmount
Alkermes, Inc.18$425
Otsuka America Pharmaceutical, Inc.21$352
E.R. Squibb & Sons, L.L.C.8$159
Teva Pharmaceuticals USA, Inc.4$93
Neurocrine BioSciences, Inc.5$88
ABBVIE INC.4$68
Vanda Pharmaceuticals Inc.2$67
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$47
Tris Pharma Inc1$22
Janssen Biotech, Inc.1$20

Products named: ARISTADA, COBENFY, REXULTI, ABILIFY ASIMTUFII, ABILIFY MAINTENA, INGREZZA, VRAYLAR, FANAPT.

Industry payments across MI — which companies pay providers there.